STERIS plc (STE) Financial Ratios
30 years of historical data (1997–2026) · Healthcare · Medical - Devices
EV/EBITDA
↓
19.40
-3% vs avg
5yr avg: 20.01
30Y Low6.1·High25.9
P/FCF
↓
20.45
↓-48% vs avg
5yr avg: 39.23
30Y Low10.9·High59.8
P/B Ratio
↓
2.78
↓-17% vs avg
5yr avg: 3.35
30Y Low1.7·High5.2
ROE
↑
11.4%
↓+70% vs avg
5yr avg: 6.7%
30Y Low-10%·High21%
Debt/EBITDA
↓
1.75
↓-23% vs avg
5yr avg: 2.28
30Y Low0.4·High4.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
STE Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
STERIS plc trades at 25.5x earnings, 68% below its 5-year average of 79.9x, sitting at the 43rd percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 16%. On a free-cash-flow basis, the stock trades at 20.4x P/FCF, 48% below the 5-year average of 39.2x.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $19.9B | $21.8B | $22.5B | $22.3B | $19.2B | $23.8B | $16.4B | $12.0B | $10.9B | $8.0B | $6.0B |
| Enterprise Value | $21.4B | $23.3B | $24.5B | $25.5B | $22.2B | $26.7B | $17.9B | $13.0B | $11.9B | $9.1B | $7.2B |
| P/E Ratio → | 25.55 | 27.89 | 36.56 | 59.01 | 178.77 | 97.49 | 41.14 | 29.41 | 35.96 | 27.54 | 54.27 |
| P/S Ratio | 3.35 | 3.68 | 4.11 | 4.35 | 4.23 | 5.63 | 5.27 | 3.95 | 3.93 | 3.05 | 2.29 |
| P/B Ratio | 2.78 | 3.03 | 3.39 | 3.54 | 3.15 | 3.63 | 4.20 | 3.51 | 3.43 | 2.49 | 2.13 |
| P/FCF | 20.45 | 22.45 | 28.86 | 36.44 | 48.55 | 59.84 | 36.33 | 31.88 | 31.28 | 27.39 | 23.81 |
| P/OCF | 14.82 | 16.27 | 19.56 | 22.95 | 25.33 | 34.71 | 23.73 | 20.30 | 20.28 | 17.49 | 14.10 |
P/E links to full P/E history page with 30-year chart
STE EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
STERIS plc's enterprise value stands at 19.4x EBITDA, roughly in line with its 5-year average of 20.0x. The Healthcare sector median is 14.2x, placing the stock at a 37% premium on an enterprise-value basis.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.93 | 4.48 | 4.97 | 4.90 | 6.32 | 5.77 | 4.27 | 4.28 | 3.48 | 2.75 |
| EV / EBITDA | 19.40 | 21.16 | 18.23 | 18.21 | 16.53 | 25.90 | 23.38 | 17.64 | 18.69 | 15.77 | 17.32 |
| EV / EBIT | 19.40 | 21.16 | 27.75 | 30.12 | 28.08 | 58.52 | 32.35 | 24.03 | 28.75 | 22.48 | 31.31 |
| EV / FCF | — | 23.98 | 31.47 | 41.63 | 56.24 | 67.22 | 39.84 | 34.44 | 34.03 | 31.20 | 28.57 |
STE Profitability
Margins and return-on-capital ratios measuring operating efficiency
STERIS plc earns an operating margin of 18.6%. Operating margins have expanded from 16.3% to 18.6% over the past 3 years, signaling improving operational efficiency. ROE of 11.4% is modest. ROIC of 9.5% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.2% | 44.2% | 44.0% | 43.2% | 43.7% | 44.6% | 43.2% | 43.6% | 42.2% | 41.7% | 39.3% |
| Operating Margin | 18.6% | 18.6% | 15.9% | 16.3% | 17.4% | 11.3% | 17.6% | 17.7% | 14.8% | 15.3% | 8.7% |
| Net Profit Margin | 13.2% | 13.2% | 11.3% | 7.4% | 2.4% | 5.8% | 12.8% | 13.5% | 10.9% | 11.1% | 4.2% |
Return on Capital
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.4% | 11.4% | 9.5% | 6.1% | 1.7% | 4.7% | 10.9% | 12.3% | 9.5% | 9.7% | 3.8% |
| ROA | 7.5% | 7.5% | 5.8% | 3.5% | 1.0% | 2.7% | 6.6% | 7.8% | 5.9% | 5.7% | 2.1% |
| ROIC | 9.5% | 9.5% | 7.2% | 6.7% | 6.4% | 4.8% | 8.3% | 9.4% | 7.3% | 7.2% | 4.1% |
| ROCE | 11.8% | 11.8% | 9.0% | 8.3% | 7.7% | 5.8% | 10.0% | 11.3% | 8.7% | 8.6% | 4.8% |
STE Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
STERIS plc carries a Debt/EBITDA ratio of 1.8x, which is manageable (45% below the sector average of 3.2x). Net debt stands at $1.5B ($1.9B total debt minus $440M cash). Interest coverage of 18.2x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.27 | 0.27 | 0.33 | 0.54 | 0.53 | 0.50 | 0.46 | 0.38 | 0.37 | 0.41 | 0.53 |
| Debt / EBITDA | 1.75 | 1.75 | 1.64 | 2.41 | 2.42 | 3.18 | 2.35 | 1.75 | 1.86 | 2.28 | 3.57 |
| Net Debt / Equity | — | 0.21 | 0.31 | 0.50 | 0.50 | 0.45 | 0.41 | 0.28 | 0.30 | 0.35 | 0.43 |
| Net Debt / EBITDA | 1.35 | 1.35 | 1.51 | 2.27 | 2.26 | 2.84 | 2.06 | 1.31 | 1.51 | 1.93 | 2.89 |
| Debt / FCF | — | 1.53 | 2.61 | 5.18 | 7.70 | 7.38 | 3.51 | 2.57 | 2.75 | 3.81 | 4.76 |
| Interest Coverage | 18.15 | 18.15 | 10.23 | 5.87 | 7.14 | 5.10 | 14.92 | 13.38 | 9.20 | 8.01 | 5.15 |
STE Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
STERIS plc's current ratio of 2.09x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 1.54x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 3.08x to 2.09x over the past 3 years.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.09 | 2.09 | 1.96 | 3.08 | 2.33 | 2.04 | 2.10 | 2.43 | 2.27 | 2.48 | 2.67 |
| Quick Ratio | 1.54 | 1.54 | 1.39 | 2.36 | 1.63 | 1.41 | 1.55 | 1.91 | 1.82 | 1.97 | 2.15 |
| Cash Ratio | 0.38 | 0.38 | 0.17 | 0.22 | 0.24 | 0.38 | 0.38 | 0.63 | 0.47 | 0.51 | 0.74 |
| Asset Turnover | — | 0.55 | 0.54 | 0.46 | 0.42 | 0.37 | 0.47 | 0.56 | 0.55 | 0.50 | 0.53 |
| Inventory Turnover | 5.24 | 5.24 | 5.26 | 4.33 | 4.23 | 4.07 | 5.60 | 6.49 | 7.72 | 7.42 | 8.02 |
| Days Sales Outstanding | — | 67.20 | 69.79 | 71.62 | 69.60 | 69.06 | 71.58 | 70.63 | 74.10 | 73.57 | 67.54 |
STE Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
STERIS plc returns 2.4% to shareholders annually — split between a 1.2% dividend yield and 1.2% buyback yield. The payout ratio of 30.8% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 3.9% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.2% | 1.1% | 1.0% | 0.9% | 1.0% | 0.7% | 0.8% | 1.0% | 1.0% | 1.3% | 1.6% |
| Payout Ratio | 30.8% | 30.8% | 35.8% | 53.0% | 171.4% | 66.9% | 33.7% | 30.2% | 37.0% | 35.4% | 84.7% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.9% | 3.6% | 2.7% | 1.7% | 0.6% | 1.0% | 2.4% | 3.4% | 2.8% | 3.6% | 1.8% |
| FCF Yield | 4.9% | 4.5% | 3.5% | 2.7% | 2.1% | 1.7% | 2.8% | 3.1% | 3.2% | 3.7% | 4.2% |
| Buyback Yield | 1.2% | 1.1% | 0.9% | 0.1% | 1.6% | 0.2% | 0.1% | 0.4% | 0.7% | 0.8% | 1.6% |
| Total Shareholder Yield | 2.4% | 2.2% | 1.9% | 1.0% | 2.6% | 0.9% | 0.9% | 1.5% | 1.8% | 2.1% | 3.2% |
| Shares Outstanding | — | $99M | $99M | $99M | $100M | $98M | $86M | $86M | $85M | $86M | $86M |
Peer Comparison
Compare STE with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 STEYou | $20B | 25.5 | 19.4 | 20.4 | 44.2% | 18.6% | 11.4% | 9.5% | 1.8 |
 WAT | $23B | 33.0 | 21.8 | 42.9 | 57.8% | 28.2% | 29.3% | 20.3% | 1.3 |
 MMSI | $4B | 31.6 | 14.0 | 18.6 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 |
 HSIC | $9B | 24.4 | 11.9 | 16.0 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 |
 IART | $1B | -2.6 | 14.4 | — | 51.7% | 4.2% | -39.9% | 1.7% | 9.3 |
 CNMD | $1B | 21.6 | 9.3 | 6.7 | 52.8% | 10.3% | 4.7% | 5.8% | 4.3 |
 SHC | $5B | 58.6 | 21.2 | 30.2 | 55.5% | 33.8% | 15.4% | 11.8% | 7.5 |
 BDX | $52B | 24.7 | 14.0 | 19.5 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 |
 BAX | $10B | -11.4 | 27.2 | 31.8 | 30.1% | -2.7% | -14.6% | -1.4% | 14.9 |
 GEHC | $28B | 13.5 | 10.0 | 18.6 | 40.0% | 13.4% | 21.6% | 13.3% | 3.0 |
 MMM | $84B | 26.8 | 16.8 | 60.0 | 39.6% | 18.3% | 75.2% | 28.1% | 2.4 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into STE consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
STE — Frequently Asked Questions
Quick answers to the most common questions about buying STE stock.
What is STERIS plc's P/E ratio?
STERIS plc's current P/E ratio is 25.5x. The historical average is 38.1x. This places it at the 43th percentile of its historical range.
What is STERIS plc's EV/EBITDA?
STERIS plc's current EV/EBITDA is 19.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.0x.
What is STERIS plc's ROE?
STERIS plc's return on equity (ROE) is 11.4%. The historical average is 10.1%.
Is STE stock overvalued?
Based on historical data, STERIS plc is trading at a P/E of 25.5x. This is at the 43th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is STERIS plc's dividend yield?
STERIS plc's current dividend yield is 1.21% with a payout ratio of 30.8%.
What are STERIS plc's profit margins?
STERIS plc has 44.2% gross margin and 18.6% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does STERIS plc have?
STERIS plc's Debt/EBITDA ratio is 1.8x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.